SAM
Silverback Asset Management’s Standard BioTools LAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,300
| Closed | -$2.51K | – | 72 |
|
|
2024
Q3 | $2.51K | Sell |
1,300
-29,958
| -96% | -$57.8K | ﹤0.01% | 78 |
|
|
2024
Q2 | $55.3K | Sell |
31,258
-93,742
| -75% | -$166K | 0.01% | 78 |
|
|
2024
Q1 | $339K | Hold |
125,000
| – | – | 0.05% | 70 |
|
|
2023
Q4 | $276K | Sell |
125,000
-175,000
| -58% | -$387K | 0.04% | 73 |
|
|
2023
Q3 | $870K | Sell |
300,000
-150,000
| -33% | -$435K | 0.12% | 74 |
|
|
2023
Q2 | $869K | Buy |
450,000
+50,000
| +13% | +$96.5K | 0.12% | 74 |
|
|
2023
Q1 | $780K | Buy |
+400,000
| New | +$780K | 0.11% | 74 |
|
|
2022
Q3 | – | Sell |
-200,000
| Closed | -$320K | – | 132 |
|
|
2022
Q2 | $320K | Hold |
200,000
| – | – | 0.05% | 69 |
|
|
2022
Q1 | $718K | Hold |
200,000
| – | – | 0.1% | 63 |
|
|
2021
Q4 | $784K | Sell |
200,000
-85,744
| -30% | -$336K | 0.09% | 56 |
|
|
2021
Q3 | $1.88M | Buy |
+285,744
| New | +$1.88M | 0.28% | 52 |
|
|
2020
Q3 | – | Sell |
-69,769
| Closed | -$280K | – | 54 |
|
|
2020
Q2 | $280K | Sell |
69,769
-304,700
| -81% | -$1.22M | 0.07% | 49 |
|
|
2020
Q1 | $951K | Buy |
374,469
+215,771
| +136% | +$548K | 0.2% | 43 |
|
|
2019
Q4 | $552K | Buy |
+158,698
| New | +$552K | 0.08% | 38 |
|
|
2018
Q2 | – | Sell |
-19,898
| Closed | -$116K | – | 46 |
|
|
2018
Q1 | $116K | Sell |
19,898
-145,102
| -88% | -$846K | 0.02% | 47 |
|
|
2017
Q4 | $972K | Buy |
165,000
+30,000
| +22% | +$177K | 0.18% | 46 |
|
|
2017
Q3 | $680K | Buy |
+135,000
| New | +$680K | 0.11% | 48 |
|